Skip to main navigation
  • About
  • Pipeline
  • Patients
  • Investors
  • Contact Us

Investor Relations

  • Investors
  • Press Releases
  • Event Calendar
  • Stock Info
  • Governance
  • Financial Info
  • Shareholder Services
  • Presentations

Financial Information

  • SEC Filings

Shareholder Tools


  • Facebook
  • Google
  • LinkedIn
  • Twitter

SEC Filing Details

Document Details

Form
8-K
Filing Date
Mar 3, 2023
Document Date
Mar 3, 2023
Form Description
Report of unscheduled material events or corporate event
Filing Group
Current Reports
Company
Bellerophon Therapeutics, Inc.
Issuer
BELLEROPHON THERAPEUTICS, INC.

Filing Formats

View HTML
Download PDF
Download DOC
Download XLS

XBRL

XBRL Viewer
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA
EX-101.LAB - EX-101.LAB
EX-101.PRE - EX-101.PRE
XML - XBRL INSTANCE DOCUMENT
© 2023 Bellerophon Therapeutics. All rights reserved.
  • Site Map
  • Terms of Use
  • Privacy Policy